MML Investors Services’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-19,389
Closed -$38K – 3284
2026
Q1
$38K Buy
19,389
+6,000
+45% +$14.1K ﹤0.01% 2952
2025
Q4
$36.3K Buy
+13,389
New +$44K ﹤0.01% 2990
2025
Q3
– Sell
-11,000
Closed -$55K – 2918
2025
Q2
$55K Buy
+11,000
New +$47.8K ﹤0.01% 2785
2022
Q2
– Sell
-10,422
Closed -$201K – 2073
2022
Q1
$201K Sell
10,422
-3,536
-25% -$81.1K ﹤0.01% 1974
2021
Q4
$456K Sell
13,958
-2,542
-15% -$102K ﹤0.01% 1466
2021
Q3
$677K Sell
16,500
-301
-2% -$10.9K 0.01% 1211
2021
Q2
$605K Buy
16,801
+2,777
+20% +$102K 0.01% 1229
2021
Q1
$547K Buy
+14,024
New +$631K 0.01% 1221

Other funds holding GDRX

MML Investors Services's GDRX Position: Q2 2026 in Review

MML Investors Services sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 19,389 shares — an estimated $38K sold.

MML Investors Services first reported a position in GDRX in Q1 2021 and held it in 8 quarters. The position peaked at $677K in Q3 2021. 163 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • MML Investors Services reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • MML Investors Services sold 19,389 GoodRx Holdings shares in Q2 2026, an estimated $38K.
  • MML Investors Services first reported a position in GoodRx Holdings in Q1 2021 and held it in 8 quarters.
  • MML Investors Services's GoodRx Holdings position peaked at $677K in Q3 2021.
  • 163 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.